 |
| Gabriel Griffin, MD |
Gabriel Griffin, MD, of the Department of Pathology, was honored with a Physician-Scientist Training Award from the Damon Runyon Cancer Research Foundation for his project “Enhancing Cancer Immunotherapy Through Epigenetic Modulation of the Repetitive Genome.”
The award recognizes cancer researchers who show bold initiative and a commitment to finding new cures. Recipients receive a $460,000 grant to pursue their research and the opportunity to retire up to $100,000 of their medical school debt.
Griffin’s research aims to identify therapeutic targets that can enhance the efficacy and scope of cancer immunotherapy. He hopes to characterize the epigenetic pathways that help tumors evade surveillance by the immune system. This basic understanding may guide the development of therapies capable of triggering anti-tumor immunity.
The Damon Runyon Cancer Research Foundation was established in memory of writer and journalist Damon Runyon, who passed away from throat cancer in 1946. Since its inception, the foundation has invested $375 million in cancer prevention, diagnosis and treatment.
